Thalidomide: Tragic past and promising futureRAJKUMAR, S. Vincent.Mayo Clinic proceedings. 2004, Vol 79, Num 7, pp 899-903, issn 0025-6196, 5 p.Article

Thalidomide : le retour = ThalidomideKNOLL, Maël.Biofutur (Puteaux). 2003, Vol 238, pp 42-43, issn 0294-3506, 2 p.Article

Thalidomide: 40 years onDIGGLE, G. E.International journal of clinical practice (Esher). 2001, Vol 55, Num 9, pp 627-631, issn 1368-5031Article

Thalidomide and sensory neurotoxicity : a neurophysiological studyZARA, G; ERMANI, M; RONDINONE, R et al.Journal of neurology, neurosurgery and psychiatry. 2008, Vol 79, Num 11, pp 1258-1261, issn 0022-3050, 4 p.Article

Thalidomide radiosensitizes tumors through early changes in the tumor microenvironmentANSIAUX, Réginald; BAUDELET, Christine; JORDAN, Bénédicte F et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 743-750, issn 1078-0432, 8 p., 1Article

The schizophrenic career of a monster drugSILVERMAN, William A.Pediatrics (Evanston). 2002, Vol 110, Num 2, pp 404-406, issn 0031-4005, 3 p., 1Article

Thalidomide sensory neurotoxicity: A clinical and neurophysiologic studyCAVALETTI, G; BERONIO, A; PLASMATI, R et al.Neurology. 2004, Vol 62, Num 12, pp 2291-2293, issn 0028-3878, 3 p.Article

Thalidomide enantiomersWINTER, W; FRANKUS, E.Lancet (British edition). 1992, Vol 339, Num 8789, issn 0140-6736, p. 365Article

Thalomid® (Thalidomide) capsules: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribingCLARK, Todd E; EDOM, Norma; LARSON, Janice et al.Drug safety. 2001, Vol 24, Num 2, pp 87-117, issn 0114-5916Article

Thalidomide in solid tumours: the resurrection of an old drugSLEIJFER, Stefan; KRUIT, Wim H. J; STOTER, Gerrit et al.European journal of cancer (1990). 2004, Vol 40, Num 16, pp 2377-2382, issn 0959-8049, 6 p.Article

Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance studyKARROW, N. A; GUO, T. L; ZHANG, L. X et al.International immunopharmacology. 2003, Vol 3, Num 10-11, pp 1447-1456, issn 1567-5769, 10 p.Article

Structural development of synthetic retinoids and thalidomide-related moleculesHASHIMOTO, Yuichi.Cancer chemotherapy and pharmacology. 2003, Vol 52, pp S16-S23, issn 0344-5704, SUP1Conference Paper

Therapeutic renaissance of thalidomide in the treatment of haematological malignanciesRIBATTI, D; VACCA, A.Leukemia. 2005, Vol 19, Num 9, pp 1525-1531, issn 0887-6924, 7 p.Article

TERATOGENICITY AND EMBRYOTOXICITY OF THALIDOMIDE AND 3-AZA-THIALIDOMIDE IN MICE = LA TERATOGENICITE ET L'EMBRYOTOXICITE DU THALIDOMIDE ET DE L'AZA-3 THALIDOMIDE CHEZ LES SOURISFICKENTSCHER K; KOEHLER F.1974; PHARMACOLOGY; SWITZ.; DA. 1974; VOL. 11; NO 4; PP. 193-198; BIBL. 6REF.Article

Thalidomide-induced sinus bradycardiaKAUR, Amandeep; YU, Susan S; LEE, Audrey J et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 1040-1043, issn 1060-0280, 4 p.Article

Thalidomide in advanced mastocytosisDAMAJ, Gandhi; BERNIT, Emmanuelle; GHEZ, David et al.British journal of haematology. 2008, Vol 141, Num 2, pp 249-253, issn 0007-1048, 5 p.Article

Extramedullary multiple myeloma escapes the effect of thalidomideROSINOL, Laura; CIBEIRA, M. Teresa; BLADE, Joan et al.Haematologica (Roma). 2004, Vol 89, Num 7, pp 832-836, issn 0390-6078, 5 p.Article

Predicting the dermal absorption of thalidomide and its derivativesHADGRAFT, J; GOOSEN, C; DU PLESSIS, J et al.Skin pharmacology and applied skin physiology. 2003, Vol 16, Num 2, pp 123-129, issn 1422-2868, 7 p.Article

Thalidomide as a novel therapeutic agent: new uses for an old productK.TEO, Steve; STIRLING, David I; ZELDIS, Jerome B et al.Drug discovery today. 2005, Vol 10, Num 2, pp 107-114, issn 1359-6446, 8 p.Article

ThalidomideFRANKS, Michael E; MACPHERSON, Gordon R; FIGG, William D et al.Lancet (British edition). 2004, Vol 363, Num 9423, pp 1802-1811, issn 0140-6736, 10 p.Article

Treatment of plasma cell dyscrasias with thalidomide and its derivativesDIMOPOULOS, Meletios A; ANAGNOSTOPOULOS, Athanasios; WEBER, Donna et al.Journal of clinical oncology. 2003, Vol 21, Num 23, pp 4444-4454, issn 0732-183X, 11 p.Article

Prise en charge d'un patient sous thalidomide = Managenment of a patient receiving thalidomideBROCVIELLE, Hélène; MURET, Patrice; PLENAT, Emmanuel et al.La Presse médicale (1983). 2003, Vol 32, Num 40, pp 1894-1898, issn 0755-4982, 5 p.Article

Treatment of prurigo nodularis with thalidomide: a case report and review of the literatureALFADLEY, Abdullah; AL-HAWSAWI, Khalid; THESTRUP-PEDERSEN, Kristian et al.International journal of dermatology. 2003, Vol 42, Num 5, pp 372-375, issn 0011-9059, 4 p.Article

Teratogen metabolism: spontaneous decay products of thalidomide and thalidomide analogues are not bioactivated by liver microsomesBRAUN, A. G; WEINREB, S. L.Teratogenesis, carcinogenesis, and mutagenesis. 1985, Vol 5, Num 3, pp 149-158, issn 0270-3211Article

Peculiarities and possible mode of actions of thalidomideNEUBERT, R; NEUBERT, D.Handbook of experimental pharmacology. 1997, Vol 124, pp 41-119, issn 0171-2004, 2Article